Comparable to the patients we describe, ORAI1- and STIM1-deficient patients suffer from recurrent severe infections and can exhibit signs of lymphoproliferation and autoimmune disease, although the disease course is often more severe, with patients requiring HSCT very early in life to prevent a lethal disease course [70, 71]. This evidence concerns the gene STIM1 and infection.